Goldman Melissa
CIK: 0001927854
Associated companies
Transaction History
| ALLY | ▲ Buy | Grant | 3,528 | $145K | 5/15/2024 | View on chart |
| ALLY | ▲ Buy | Grant | 931 | $0 | 1/5/2024 | View on chart |
| ALLY | ▲ Buy | Grant | 1,219 | $0 | 10/6/2023 | View on chart |
| ALLY | ▲ Buy | Grant | 1,204 | $0 | 7/6/2023 | View on chart |
| ALLY | ▲ Buy | Grant | 5,673 | $145K | 5/15/2023 | View on chart |
| ALLY | ▲ Buy | Grant | 1,276 | $0 | 4/7/2023 | View on chart |
| ALLY | ▲ Buy | Grant | 1,330 | $0 | 1/10/2023 | View on chart |
| ALLY | ▲ Buy | Grant | 1,168 | $0 | 10/6/2022 | View on chart |
| ALLY | ▲ Buy | Grant | 629 | $0 | 7/8/2022 | View on chart |
| ALLY | ▲ Buy | Grant | 3,664 | $145K | 5/13/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Wells Fargo Downgrades Ally Financial to Equal-Weight
Wells Fargo downgraded Ally Financial to Equal-Weight and lowered its price target to $42. This action stands out against a broader analyst consensus that currently averages a $51.95 target. The stock is trading near its 52-week low, reflecting recent market pressure despite a valuation that some analysts view as undervalued.
Wells Fargo Downgrades Ally Financial to Equal-Weight. Wells Fargo downgraded Ally Financial to Equal-Weight and lowered its price target to $42. This action stands out against a broader analyst consensus that currently averages a $51.95 target. The stock is trading near its 52-week low, reflecting recent market pressure despite a valuation that some analysts view as undervalued.